mazetx.com (MAZE) Company Sales Revenue

Corporate emblem and logo of Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Inc (MAZE) utilizes AI gene mapping to develop unique, patent-protected medicines. The company's commercial sales metric on the GURU.Markets daily chart reflects revenue dynamics, where 0.02 represents the latest data point for this metric. While robotic synthesis accelerates molecular design, the R&D stage and lack of profitability are temporarily increasing laboratory expenses.

Maze Therapeutics, Inc. (MAZE): Company Revenue from 02/01/2025 to 11/18/2026

Analytical breakdowns for Maze Therapeutics, Inc. (MAZE)

- market price and analyst price targets:
General company analysis:Maze Therapeutics Inc, MAZE
Original product of Maze Therapeutics

Maze Therapeutics Inc (MAZE) is developing a closed ecosystem of genetic drugs for the treatment of rare diseases. Daily cash inflows capture the real-time monetization of this model, reflecting the actual capital inflow from clients. This metric measures the issuer's operational resilience during periods of market volatility, excluding speculative expectations. It is critical for investors to monitor the stability of cash flows to assess business viability while undergoing FDA certification. The volume of the company's realized products clearly demonstrates its current financial strength.

Key competitors

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Sionna Pharma - Company Total Sales|Prime Medicine (PRME) - Company Revenue|tayshagtx.com (TSHA) - Revenue and Sales Volume|Company Revenue uniQure Corp|MGTX: Company Sales Revenue|Revenue and Sales Volume RGNX|Company Gross Revenue Solid Corp|Revenue and Sales Volume OCGN (ocugen.com)|PACB (Pacific Biosciences) - Company Annual Revenue|Benitec Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Company Revenue|4D Molecular Therapeutics (FDMT) - Revenue and Sales Volume|LXEO (Lexeo Therapeutics, Inc.) - Revenue and Sales Volume|Company Total Revenue korrobio.com KRRO|Company Sales EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Company Sales Volume|Company Revenue ProQR Therapeutics N.V. PRQR|Company Gross Revenue Codexis, Inc. (CDXS)|SGMO - Company Revenue|nautilus.bio - Company Total Sales|Metagenomi, Inc (MGX) - Company Revenue|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales